Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company

International Journal of Technology Assessment in Health Care
Pierre DucournauMarlene Gyldmark

Abstract

Evidence requirements and assessment methods access differ between health technology assessment (HTA) agencies. The HTA Core Model® provides a standardized approach to HTA, targeting evidence sharing and collaboration between participating HTA bodies. It is fit for purpose from an industry perspective and was used by pharmaceutical company Roche to develop a framework for internal assessment of evidence required for market access and coverage/reimbursement ("access evidence"). Tools were developed to systematically scope, assess, plan, and summarize access evidence generation. The tools were based mainly on the first four HTA Core Model® domains and rolled-out in selected development teams in 2017. Five months after full implementation, the impact of tools was assessed in an internal survey. Systematic access evidence generation started with the Access Evidence Questionnaire, to scope evidence requirements and identify evidence gaps. Findings were summarized in the Access Evidence Metric, which assessed the alignment of available/planned evidence against HTA bodies' requirements and developed scope mitigation strategies. The Access Evidence Plan was then used to plan and document (additional) evidence generation. Once generated...Continue Reading

References

Jun 5, 2004·International Journal of Technology Assessment in Health Care·Mickael Lothgren, Mark Ratcliffe
Jan 18, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael DrummondAleksandra Torbica
Jul 13, 2013·International Journal of Technology Assessment in Health Care·Chris HenshallUNKNOWN HTAi Policy Forum
Dec 3, 2013·International Journal of Technology Assessment in Health Care·Andreas Fibig
Jan 24, 2014·International Journal of Technology Assessment in Health Care·Giovanni RadaelliMichele Tringali
Dec 10, 2015·International Journal of Technology Assessment in Health Care·Karen FaceySarah Thomas
Aug 4, 2016·Health Economics Review·Ulrike Theidel, J-Matthias Graf von der Schulenburg
Feb 19, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ronald L AkehurstFrançois Sarkozy
Feb 27, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Finn Børlum KristensenLidia Becla
Jun 10, 2017·International Journal of Technology Assessment in Health Care·Karen Macpherson, Lorna Thompson
Oct 2, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Wija OortwijnJeroen van der Tuin
Nov 22, 2017·International Journal of Technology Assessment in Health Care·Kristina KõrgeMickael Hiligsmann
Dec 21, 2017·International Journal of Technology Assessment in Health Care·Katharina HawlikClaudia Wild
Feb 27, 2018·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Darius N LakdawallaPatricia M Danzon
Oct 20, 2018·International Journal of Technology Assessment in Health Care·Marlene GyldmarkFinn Børlum Kristensen

❮ Previous
Next ❯

Citations

Jun 6, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Bertalan NémethZoltán Kaló

❮ Previous
Next ❯

Software Mentioned

Access Evidence Dossier
Access
AEx
# TAg
HTA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Technology Assessment in Health Care
Marlene GyldmarkFinn Børlum Kristensen
International Journal of Technology Assessment in Health Care
Fabienne QuentinEuropean network for Health Technology Assessment (EUnetHTA)
International Journal of Technology Assessment in Health Care
Matthieu CucheMarije A van Weelden
International Journal of Technology Assessment in Health Care
Kristian LampeEuropean network for Health Technology Assessment (EUnetHTA)
International Journal of Technology Assessment in Health Care
Sabine FuchsReinhard Busse
© 2022 Meta ULC. All rights reserved